Senate Passes Bill for Better Sunscreen

The Senate passed a bill Wednesday that requires the Food and Drug Administration (FDA) to respond to current pending sunscreen ingredients within a shorter period of time—an important factor in ensuring that people have the most up-to-date ways to protect their skin from cancer-causing UVA rays, proponents of the legislation have argued.

While skin cancer is the most common cancer diagnosed in the U.S., eight sunscreen ingredients have been pending in FDA backlog for years—some for over a decade—even while several of the pending ingredients have already been used in Europe and Asia for years.